These top small-caps were some of the few gainers on the TSX in 2022. But are these stocks worth buying in 2023? The post 2022’s Top Small Caps on the TSX: Are They Buys Today? appeared first on The Motley Fool Canada.
Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market. The post 3 Biotech Stocks to Buy Before the Down Market Is Over appeared first on The Motley Fool Canada.
BELLUS Health ( TSE:BLU ) Third Quarter 2022 Results Key Financial Results Net loss: US$24.7m (loss widened by 8.0...